Get started
Author

Charlotte C. van Ruiten

Observed names: Charlotte C van Ruiten, Charlotte van Ruiten, van Ruiten, Charlotte, van Ruiten, Charlotte C., van Ruiten, Charlotte Constance
ORCID: 0000-0002-6123-5140
Observed ORCID: 0000-0002-6123-5140
OpenAlex ID: A5013989864
SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management
2018 · Michaël J.B. van Baar, Charlotte C. van Ruiten, et al. · Diabetes Care · 212
Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial
2021 · Charlotte C. van Ruiten, Annemarie B van der Aart‐van der Beek, et al. · Diabetes Obesity and Metabolism · 59
PDF
Mechanisms underlying the blood pressure lowering effects of dapagliflozin, exenatide, and their combination in people with type 2 diabetes: a secondary analysis of a randomized trial
2022 · Charlotte C. van Ruiten, Mark M. Smits, et al. · Cardiovascular Diabetology · 58
PDF
Effects of Dapagliflozin and Combination Therapy With Exenatide on Food-Cue Induced Brain Activation in Patients With Type 2 Diabetes
2022 · Charlotte C van Ruiten, Dick J Veltman, et al. · The Journal of Clinical Endocrinology & Metabolism · 37
PDF
Eating behavior modulates the sensitivity to the central effects of GLP-1 receptor agonist treatment: a secondary analysis of a randomized trial
2022 · Charlotte C. van Ruiten, Jennifer S. ten Kulve, et al. · Psychoneuroendocrinology · 36
PDF
Combination therapy with exenatide decreases the dapagliflozin‐induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trial
2022 · Charlotte C. van Ruiten, Dick J. Veltman, et al. · Diabetes Obesity and Metabolism · 22
Personalized Dietary Advice to Increase Protein Intake in Older Adults Does Not Affect the Gut Microbiota, Appetite or Central Processing of Food Stimuli in Community-Dwelling Older Adults: A Six-Month Randomized Controlled Trial
2023 · Kristina S. Fluitman, Madelief Wijdeveld, et al. · Nutrients · 17
PDF
Brain Activation in Response to Low-Calorie Food Pictures: An Explorative Analysis of a Randomized Trial With Dapagliflozin and Exenatide
2022 · Charlotte C. van Ruiten, Dick J. Veltman, et al. · Frontiers in Endocrinology · 15
PDF
Sodium glucose cotransporter-2 inhibitors protect the cardiorenal axis: Update on recent mechanistic insights related to kidney physiology
2022 · Charlotte C. van Ruiten, Anne C. Hesp, et al. · European Journal of Internal Medicine · 10
PDF
Erratum: SGLT2 inhibitors in combination therapy: From mechanisms to clinical considerations in type 2 diabetes management. (Diabetes Care (2018) 41 (1543–1556) DOI: 10.2337/dc18-0588)
2019 · van Baar, Michaël J. B., van Ruiten, Charlotte C., et al. · Pure Amsterdam UMC · 2
Synergistic and Distinct Central Effects of Dapagliflozin and Exenatide on Brain Networks Intrinsic Connectivity in Obesity and Type 2 Diabetes: A Randomized Controlled Trial (P1-13.001)
2026 · Jonadab Dos Santos Silva, Charlotte van Ruiten, et al. · Neurology
Author response for "Combination therapy with exenatide decreases the dapagliflozin-induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trial"
2022 · van Ruiten, Charlotte C., Veltman, Dick J., et al. · Publons reviews and discussion
Author response for "Effect of exenatide twice daily and dapagliflozin alone and in combination on markers of kidney function in obese patients with type 2 diabetes: a prespecified secondary analysis of a randomized controlled clinical trial"
2021 · Charlotte C. van Ruiten, Annemarie B van der Aart‐van der Beek, et al. · Publons reviews and discussion
Erratum. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management. Diabetes Care 2018;41:1543–1556
2019 · Michaël J.B. van Baar, Charlotte C. van Ruiten, et al. · Diabetes Care
Works count: 16
Citation count: 468
H-index: 9
I10-index: 9
Year
Topic
Type